Feb 12, 2013 by Max Macaluso1 Big Catalyst for Amarin Investors... MaybeThe (potential) NCE decision is upon us once again.
Feb 11, 2013 by Max MacalusoIs This an Anchor for Eli Lilly Investors?One top-selling drug that won't lose patent protection this year.
Feb 8, 2013 by Max MacalusoMerck's Fight for Fat ProfitsWas Merck able to defend its patents in court?
Feb 8, 2013 by Max MacalusoEli Lilly’s Biggest Problem in 2013What is the one risk investors need to know this year?
Feb 7, 2013 by Max MacalusoIs This Merck's Secret Weapon?This experimental Alzheimer's disease drug could drive growth.
Feb 6, 2013 by Max MacalusoCan Merck Buy Its Way Out of Trouble?This giant drugmaker has been stagnant lately - is an acquisition on the cards?
Jan 31, 2013 by Max MacalusoWhy Sell This Pharma Dividend Stock Today?Why Sell Merck? Here are 3 things to think about.
Jan 31, 2013 by Max MacalusoWhy Shares of Celsion Got Crushed TodayWhat caused shares of this drugmaker to spiral today?
Jan 30, 2013 by Max Macaluso3 Areas Merck Investors Need to TrackThe three things Merck investors need to be watching closely.
Jan 29, 2013 by Max MacalusoWhy Shares of Anacor Pharma Crumbled TodayThe drug met its primary endpoint - so why the drop?
Jan 29, 2013 by Max MacalusoCan Keryx Continue Climbing?After yesterday's jump, why is Keryx still on a roll?
Jan 28, 2013 by Max Macaluso3 Risks Merck Investors Need to KnowWhat are the biggest risks to Merck investors today?
Jan 28, 2013 by Max MacalusoWhy Shares of Repros CrateredWhat investors need to know about today's drop.
Jan 25, 2013 by Max MacalusoWhat Will Drive Merck's Growth in 2013?Does this big pharma have more opportunities ahead?
Jan 24, 2013 by Max MacalusoAriad Needs Money to Make MoneyAriad's public offering should bring in plenty of cash for 2013.
Jan 24, 2013 by Max MacalusoGoodbye, Watson Pharmaceuticals -- Hello, ActavisWatson Pharmaceuticals has a new identity on the NYSE.
Jan 24, 2013 by Max MacalusoThe Day Amarin Investors Have Waited ForIt's finally here... but it's not NCE.
